financetom
Business
financetom
/
Business
/
TotalEnergies CEO says NextDecade to announce FID on Rio Grande LNG train on Tuesday, CNBC reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TotalEnergies CEO says NextDecade to announce FID on Rio Grande LNG train on Tuesday, CNBC reports
Sep 9, 2025 3:56 AM

PARIS, Sept 9 - TotalEnergies CEO Patrick

Pouyanne said that U.S. liquefied natural gas developer

NextDecade ( NEXT ), in which Total holds a stake, will announce a final

investment decision on an additional liquefaction unit at its

Rio Grande LNG project later on Tuesday, in an interview with

CNBC.

The comments were made on the sidelines of the GasTech

conference in Milan on Tuesday.

"For a company like TotalEnergies, the U.S. has plenty of

energy - we invest in the Gulf of Mexico with Chevron ( CVX ), we

continue to explore gas and LNG, and we will announce a new

train for Rio Grande LNG; the FID will be announced today,"

Pouyanne said.

Pouyanne added that he would meet with the U.S. energy

and interior secretaries on Tuesday to discuss the French energy

company's investments in the country.

NextDecade ( NEXT ) did not immediately respond to a request for

comment outside of U.S. business hours.

The Texas-based LNG producer has previously said it was

targeting mid-September

for a FID on a fourth and fifth train, or liquefaction

unit, at Rio Grande.

LNG developers typically reach an FID on projects once

they have secured enough supply deals to obtain the necessary

financing for construction.

On Monday, NextDecade ( NEXT ) announced it had fully

commercialized Train 5, with the signing of a 20-year

supply agreement

with ConocoPhillips ( COP ).

TotalEnergies, the largest offtaker of U.S. LNG, has a

17.5% stake in NextDecade ( NEXT ) and a 16.7% interest in Phase 1 of the

Rio Grande project, which includes the first three trains.

In April, it signed a 20-year deal to purchase 1.5

million tons per annum (mtpa) from Train 4, although Reuters

reported last month Total had

declined its option

to invest in Train 5.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
LSL Pharma to Acquire Quebec Competitor for $2.5 Million to Expand Natural-Product Offerings
LSL Pharma to Acquire Quebec Competitor for $2.5 Million to Expand Natural-Product Offerings
May 6, 2024
08:18 AM EDT, 05/06/2024 (MT Newswires) -- LSL Pharma Group ( LPGIF ) on Monday said it will acquire a rival pharmaceutical manufacturer for $2.5 million in cash to expand its contract-manufacturing of natural health products. LSL identified the company only as a Quebec-based competing contract drug manufacturer (CDMO) specialized in the formulation, production, and marketing of natural products. LSL...
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
May 6, 2024
May 6 (Reuters) - Gossamer Bio ( GOSS ) said on Monday it will collaborate with Italian drugmaker Chiesi Group to develop and commercialize its therapy seralutinib in multiple indications related to high blood pressure due to constriction of lung arteries. The therapy is currently in late-stage development for the treatment of pulmonary arterial hypertension (PAH), which affects about 40,000...
Block Plans $1.5 Billion Senior Notes Offering
Block Plans $1.5 Billion Senior Notes Offering
May 6, 2024
08:18 AM EDT, 05/06/2024 (MT Newswires) -- Block (SQ) said Monday it plans a private placement of $1.5 billion in senior notes. The company and the purchasers have yet to set the interest rate, redemption provisions, maturity date, and other terms of the notes. Block intends to use the net proceeds from this offering for general corporate purposes, which may...
Spectral Medical Says 105 Patients Now Enrolled in Tigris Trial
Spectral Medical Says 105 Patients Now Enrolled in Tigris Trial
May 6, 2024
08:16 AM EDT, 05/06/2024 (MT Newswires) -- Spectral Medical ( EDTXF ) , which is advancing therapeutic options for sepsis and septic shock, on Monday provided an update on its Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (PMX) in a trial of adults treated for endotoxemia and septic shock. The company reports that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved